Table 2.
MSA prion propagation in Tg(SNCA) mice.
Patient Sample | Mean cell infection ± SD, fluorescence/cell (103 A.U.)* | ||
---|---|---|---|
Tg(SNCA+/+)Nbm | Tg(SNCA*A30P+/+)Nbm | Tg(SNCA*A53T+/+)Nbm | |
C2 | 2.4 ± 1.0 | 1.6 ± 0.3 | 1.8 ± 0.8 |
C3 | 2.4 ± 1.0 | 2.0 ± 0.9 | 2.1 ± 1.0 |
C14 | 1.4 ± 0.3 | 1.9 ± 0.5 | 3.3 ± 3.5 |
C16 | 2.4 ± 1.0 | 1.9 ± 0.5 | 2.0 ± 0.6 |
C17 | 1.3 ± 0.4 | 1.7 ± 0.5 | 2.1 ± 0.4 |
MSA6 | 1.9 ± 0.4 | 3.3 ± 1.8 | 78 ± 12 |
MSA13 | 2.3 ± 0.6 | 1.8 ± 0.4 | 39 ± 22 |
MSA16 | 1.8 ± 0.3 | 2.3 ± 1.1 | 29 ± 26 |
MSA17 | 1.6 ± 0.7 | 1.7 ± 0.5 | 13 ± 16 |
MSA18 | 1.3 ± 0.1 | 4.0 ± 6.2 | 9.2 ± 10 |
Measurements made from five images per well, n = 6 wells. PTA-precipitated samples were diluted in DPBS 1:10 before testing on α-syn140*A53T–YFP cells.